APA (7th ed.) Citation

O'Farrell, M., Duke, G., Crowley, R., Buckley, D., Martins, E. B., Bhattacharya, D., . . . Kemble, G. (2022). FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models. Scientific Reports, 12(1), 1. https://doi.org/10.1038/s41598-022-19459-z

Chicago Style (17th ed.) Citation

O'Farrell, Marie, Greg Duke, Richard Crowley, Douglas Buckley, Eduardo B. Martins, Dipankar Bhattacharya, Scott L. Friedman, and George Kemble. "FASN Inhibition Targets Multiple Drivers of NASH by Reducing Steatosis, Inflammation and Fibrosis in Preclinical Models." Scientific Reports 12, no. 1 (2022): 1. https://doi.org/10.1038/s41598-022-19459-z.

MLA (9th ed.) Citation

O'Farrell, Marie, et al. "FASN Inhibition Targets Multiple Drivers of NASH by Reducing Steatosis, Inflammation and Fibrosis in Preclinical Models." Scientific Reports, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1038/s41598-022-19459-z.